Serum alpha-fetoprotein level is often elevated in patients with chronic liver disease and patients with hepatocellular carcinoma. One of the most difficult problems frequently encountered in practice is differentiating hepatocellular carcinoma from chronic liver disease. This study investigated the
Apolipoproteinemia A and α-fetoprotein in the diagnosis of hepatocellular carcinoma and cirrhosis: Several interpretations
✍ Scribed by Thierry Poynard
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 267 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
✦ Synopsis
The serum apolipoprotein A (Apo A) and afetoprotein (AFP) were evaluated in histologically verified 30* cases of alcoholic cirrhosis and 18 cases of hepatocellular carcinoma (HCC). The latter were also divided into subgroups depending on the presence or *Abstracts are republished exactly as they were originally published.
📜 SIMILAR VOLUMES
We report here on three patients with cirrhosis for whom an early recognition of hepatocellular carcinoma was made possible by the measurement of the degree of fucosylation (fucosylation index) of a-fetoprotein. Increased levels of this index associated with a moderate increment of serum concentrati
For an approach of gene therapy for hepatocellular carcinoma (HCC), transcriptional regulatory sequence (TRS) of either alpha-fetoprotein (AFP) or albumin has been used for targeting cancer cells. To examine the feasibility of using TRSs of these genes for possible gene therapy of HCCs, the cellular
Clinicopathological features were studied in 4 1 patients with histology-proven hepatocellular carcinoma without cirrhosis. Of these, 13 (31.7%) were positive for hepatitis B virus surface antigen (HBsAg) and 28 were negative. Twenty-six of 28 (92.9%) HBsAg negative cases had anticore antibody (anti
Detection of hypercoagulable state might be helpful in the diagnosis of primary hepatocellular carcinoma (HCC) complicating liver cirrhosis (LC). Plasma levels of thrombin-antithrombin 111 complex (TAT) were determined in 50 patients of LC with or without HCC. The levels were above 2 ng/ml in 80% of